GL1X · GenesisL1 explorer

Research workbench

Human P38 MAP kinase in complex with RL182

Analyse Human P38 MAP kinase in complex with RL182 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3PG3
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.11.24
UniProt
Q16539
Ligands
DG7
Pockets
3 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.11.24)protein33738% helix, 14% strandQ16539

Ligands and binding sites

  • DG7 · 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-{4-[2-(pyridin-3-ylmethoxy)ethyl]-1,3-thiazol-2-yl}urea · ligand · chains A
  • BOG · octyl beta-D-glucopyranoside · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14390.730.8348DG7
22400.650.8228BOG
33670.610.7760empty

Compared structures

  • 3PG3 · Human p38 MAP Kinase in Complex with RL182 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.